Covid-19 - Navigating the uncharted

New England Journal of Medicine

Volumn 382, Issue 13, 2020, Pages 1268-1269

  Fauci, Anthony S ^a   Lane, H Clifford ^a   Redfield, Robert R ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; CHLOROQUINE; LOPINAVIR PLUS RITONAVIR; REMDESIVIR;

CASE FATALITY RATE; CHINA; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; EDITORIAL; HOSPITALIZATION; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME; MORBIDITY; MORTALITY; PANDEMIC INFLUENZA; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; SARS-RELATED CORONAVIRUS; SEASONAL INFLUENZA; SEVERE ACUTE RESPIRATORY SYNDROME; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SOCIAL DISTANCE; TELECOMMUTING; VIRUS TRANSMISSION; BETACORONAVIRUS; CORONAVIRINAE; VIRUS PNEUMONIA;

BETACORONAVIRUS; CHINA; CORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; PNEUMONIA, VIRAL;

EID: 85081250192     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe2002387     Document Type: Editorial

References (12)

1. Pneumonia of unknown cause - China: Disease outbreak news. Geneva: World Health Organization, January 5, 2020 (https://www.who.int/csr/don/05 -january -2020 -pneumonia -of -unkown -cause -china/en/).
2. de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: Recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14: 523-34.
3. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med 2020; 382: 1199-207.
4. Coronavirus disease 2019 (COVID-19): Situation report - 36. Geneva: World Health Organization, February 25, 2020 (https://www.who.int/docs/default -source/coronaviruse/situation -reports/20200225 -sitrep -36 -covid -19.pdf?sfvrsn=2791b4e0_2).
5. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. DOI: 10.1056/NEJMoa2002032.
6. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382: 929-36.
7. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382: 1177-9.
8. Coronavirus disease 2019 (COVID-19) in the U.S. Atlanta: Centers for Disease Control and Prevention, February 26, 2020 (https://www.cdc.gov/coronavirus/2019 -ncov/cases -in -us.html).
9. Fong MW, Gao H, Wong JY, et al. Nonpharmaceutical measures for pandemic influenza in nonhealthcare settings - social distancing measures. Emerging Infect Dis 2020; 26(5) (Epub ahead of print).
10. DRAFT landscape of COVID-19 candidate vaccines - 18 February 2020. Geneva: World Health Organization (https://www.who.int/blueprint/priority -diseases/key -action/list -of -candidate -vaccines -developed -against -ncov.pdf).
11. WHO R&D blueprint: Informal consultation on prioritization of candidate therapeutic agents for use in novel coronavirus 2019 infection. Geneva: World Health Organization, January 24, 2020 (https://apps.who.int/iris/bitstream/handle/10665/330680/WHO -HEO -RDBlueprint% 28nCoV%29 -2020.1 -eng.pdf).
12. Lane HC, Marston HD, Fauci AS. Conducting clinical trials in outbreak settings: Points to consider. Clin Trials 2016; 13: 92-5.